Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: Comparison of diabetic retinopathy (DR) severity between autonomous Artificial Intelligence (AI)-based outputs from an FDA-approved screening system and human retina specialists’ gradings from ultra-widefield (UWF) colour images. Methods: Asymptomatic diabetics without a previous diagnosis of DR were included in this prospective observational pilot study. Patients were imaged with autonomous AI (IDx-DR, Digital Diagnostics). For each eye, two 45° colour fundus images were analysed by a secure server-based AI algorithm. UWF colour fundus imaging was performed using Optomap (Daytona, Optos). The International Clinical DR severity score was assessed both on a 7-field area projection (7F-mask) according to the early treatment diabetic retinopathy study (ETDRS) and on the total gradable area (UWF full-field) up to the far periphery on UWF images. Results: Of 54 patients included (n = 107 eyes), 32 were type 2 diabetics (11 females). Mean BCVA was 0.99 ± 0.25. Autonomous AI diagnosed 16 patients as negative, 28 for moderate DR and 10 for having a vision-threatening disease (severe DR, proliferative DR, diabetic macular oedema). Based on the 7F-mask grading with the eye with the worse grading defining the DR stage 23 patients were negative for DR, 11 showed mild, 19 moderate and 1 severe DR. When UWF full-field was analysed, 20 patients were negative for DR, while the number of mild, moderate and severe DR patients were 12, 21, and 1, respectively. Conclusions: The autonomous AI-based DR examination demonstrates sufficient accuracy in diagnosing asymptomatic non-proliferative diabetic patients with referable DR even compared to UWF imaging evaluated by human experts offering a suitable method for DR screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 1×
“Diabetic retinopathy (DR) is a vision-threatening disease affecting approximately one-third of individuals diagnosed with diabetes mellitus [1].”
BackgroundTing, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638
Abràmoff, M. D., Lou, Y., Erginay, A., Clarida, W., Amelon, R., Folk, J. C., & Niemeijer, M. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-19964 · Cited by 1,101
van der Heijden, A. A., Abramoff, M. D., Verbraak, F., van Hecke, M. V., Liem, A., & Nijpels, G. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13613 · Cited by 296 · cited 1×
“IDx-DR was applied in a real-life setting in a Dutch population of 1410 patients with a reported sensitivity of 68% and speci fi city of 86% compared to the ICDR grading [26].”
Foundational Considerations for Artificial Intelligence Using Ophthalmic Images
Abràmoff, M. D., Cunningham, B., Patel, B., Eydelman, M. B., Leng, T., Sakamoto, T., Blodi, B., Grenon, S. M., Wolf, R. M., Manrai, A. K., et al. (2022) · Ophthalmology · doi:10.1016/j.ophtha.2021.08.023 · Cited by 96
Shah, A., Clarida, W., Amelon, R., Hernaez-Ortega, M. C., Navea, A., Morales-Olivas, J., Dolz-Marco, R., Verbraak, F., Jorda, P. P., van der Heijden, A. A., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820906212 · Cited by 68 · cited 1×
“A recent study conducted by Shah et al. in a Spanish population of 2680 subjects revealed 100% sensitivity and 82% speci fi city for IDx-DR for detecting referable DR and 100% sensitivity and 95% speci fi city for detecting vision-threatening DR compared to manual gradings [27].”
Result
Cited by
JOSEPH, S., SELVARAJ, J., MANI, I., KUMARAGURUPARI, T., SHANG, X., MUDGIL, P., RAVILLA, T., & HE, M. (2024) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2024.02.012 · Cited by 69
KHAN, Z., GAIDHANE, A. M., SINGH, M., GANESAN, S., KAUR, M., SHARMA, G. C., RANI, P., SHARMA, R., THAPLIYAL, S., KUSHWAHA, M., et al. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.02.022 · Cited by 49
Grzybowski, A., Rao, D. P., Brona, P., Negiloni, K., Krzywicki, T., & Savoy, F. M. (2023) · Ophthalmic Research · doi:10.1159/000534098 · Cited by 33
Metadata
- Authors
- Sedova, A., Hajdu, D., Datlinger, F., Steiner, I., Neschi, M., Aschauer, J., Gerendas, B. S., Schmidt-Erfurth, U., & Pollreisz, A.
- Venue
- Eye
- Published
- 2022-02-07
- Volume
- 36
- Issue
- 3
- Pages
- 510-516
- ISSN
- 0078-5334 (ISSN-L)
- 0950-222X
- 1476-5454
- OpenAlex
- W4210825616
- Cited by
- 35
- References
- 7
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images. https://app.cochat.ai/papers/10.1038/s41433-021-01912-4
- The paper
- Sedova, A., Hajdu, D., Datlinger, F., Steiner, I., Neschi, M., Aschauer, J., Gerendas, B. S., Schmidt-Erfurth, U., & Pollreisz, A. (2022). Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images. Eye. https://doi.org/10.1038/s41433-021-01912-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.